|
Status |
Public on Apr 28, 2016 |
Title |
Sp7/Osterix is restricted to bone-forming vertebrates where it acts as a Dlx co-factor in osteoblast specification |
Organism |
Mus musculus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Contributor(s) |
Hojo H, Ohba S, He X, Lai LP, McMahon AP |
Citation(s) |
27134141 |
|
Submission date |
Dec 20, 2015 |
Last update date |
Jun 16, 2021 |
Contact name |
Hironori Hojo |
E-mail(s) |
[email protected]
|
Phone |
+81-3-5841-1427
|
Organization name |
The University of Tokyo
|
Department |
Center for Disease Biology and Integrative Medicine
|
Lab |
Clinical Biotechnology
|
Street address |
7-3-1 Hongo
|
City |
Bunkyo-ku |
State/province |
Tokyo |
ZIP/Postal code |
113-8655 |
Country |
Japan |
|
|
Platforms (2) |
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
Samples (26)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE76185 |
Sp7/Osterix is restricted to bone-forming vertebrates where it acts as a Dlx co-factor in osteoblast specification [ChIP-Seq] |
GSE76186 |
Sp7/Osterix is restricted to bone-forming vertebrates where it acts as a Dlx co-factor in osteoblast specification [RNA-Seq] |
GSE80231 |
Sp7/Osterix is restricted to bone-forming vertebrates where it acts as a Dlx co-factor in osteoblast specification [ChIP-Seq 2] |
|
Relations |
BioProject |
PRJNA306573 |